The Peptide Progress Independent peptide research guides

Research library

CJC-1295 with DAC versus “no DAC”

The common comparison begins with a naming problem: “no DAC” is not a precise chemical identity.

By The Peptide Progress Editorial TeamLast reviewed 19 September 2026Reading time 7 minutesCited sources 2

Research context only

This article describes terminology, published research and analytical questions. It does not establish clinical benefit, safety or approval and gives no personal-use guidance.

Overview

CJC-1295 is associated with a growth-hormone-releasing-hormone analogue designed with a drug-affinity-complex (DAC) component. Online, “CJC-1295 no DAC” is often used for a different peptide commonly associated with modified GRF(1-29). Those labels should not be treated as one compound with a minor option.

Identity and naming

Exact sequence, substitutions, terminal groups and conjugation chemistry are essential. A COA titled only “CJC-1295” leaves the central identity question unresolved.

What the evidence does—and does not—show

Pharmacokinetic and endocrine research on a DAC-conjugated analogue does not automatically apply to a non-conjugated sequence. Search terms and supplier categories frequently blur that distinction.

Analytical questions

  • State the complete structure behind “DAC” or “no DAC”.
  • Check theoretical mass against the declared form.
  • Use sequence-sensitive evidence where isomers or close analogues are plausible.
  • Do not infer identity from retention time alone.

For document checks, use the COA guide and testing-method overview.

Reading supplier and search claims

A research paper and a batch report answer different questions. Published literature may explain why a compound is studied; it does not verify the identity, content, sterility or provenance of material offered under the same name. Read supplier statements as claims to check, then match the physical batch to the laboratory evidence.

Related external reading:

Editorial reference only; not an endorsement or batch verification.

Frequently asked questions

Is CJC-1295 no DAC simply CJC-1295 without one ingredient?

The label is commonly used for a materially different molecular entity, so exact sequence and structure are necessary.

Can the two names share one COA?

No. Each distinct material and batch needs documentation that unambiguously identifies it.

Sources and further reading

  1. Teichman SL et al. Prolonged stimulation of growth hormone and IGF-I by CJC-1295. Search PubMed.
  2. IUPAC peptide terminology.

External sources were checked on 19 September 2026. A citation supports the statement beside it; it does not imply that a source endorses this publication or any supplier.